Visser, Martijn ; Amarakoon, Sankha ; Missotten, TOAR.. Visser , M , Amarakoon , S , Missotten , TOAR , Timman , R & van Busschbach , J 2020 , ' Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial ' , Quality of Life Research , vol. 29 , no. 12 , pp. 3305-3313 . https://doi.org/10.1007/s11136-020-02580-9.
,
2020